Dionyssios Katsaros

发表

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

Artemis G. Hatzigeorgiou, Victor A. Simossis, Praveen Sethupathy, 2008, Proceedings of the National Academy of Sciences.

Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.

Enrica Calura, Chiara Romualdi, Duccio Cavalieri, 2011, The Lancet. Oncology.

A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast Cancer

Franck Molina, Charles Theillet, Nicolas Salvetat, 2008, Clinical Cancer Research.

Integrative Genomic Analysis of Phosphatidylinositol 3′-Kinase Family Identifies PIK3R3 as a Potential Therapeutic Target in Epithelial Ovarian Cancer

Joel Greshock, George Coukos, N. Yang, 2007, Clinical Cancer Research.

MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.

Joel Greshock, Stefano Volinia, George Coukos, 2008, Cancer research.

A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer.

Joel Greshock, George Coukos, Xiaowen Hu, 2012, Cancer research.

Differential Expression of a Human Kallikrein 5 (KLK5) Splice Variant in Ovarian and Prostate Cancer

Klaus Jung, George M Yousef, Carsten Stephan, 2004, Tumor Biology.

Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer

Gianluca Gregori, Chiara Benedetto, Qian Deng, 2012, Breast Cancer Research and Treatment.

The Heterochronic microRNA let-7 Inhibits Cell Motility by Regulating the Genes in the Actin Cytoskeleton Pathway in Breast Cancer

Jinyi Guo, Xia Zhao, Chiara Benedetto, 2013, Molecular Cancer Research.

The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.

Ignace Vergote, Andreas Scorilas, Marco Massobrio, 2003, Cancer research.

Genomic instability and copy‐number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas

Yingye Zheng, Jane Bayani, D. Katsaros, 2011, Molecular oncology.

Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics

Herbert Yu, D. Katsaros, Herbert Yu, 2009, Breast Cancer Research and Treatment.

Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer

Harvey Risch, Brenda Y. Hernandez, Herbert Yu, 2015, Oncotarget.

A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer.

Hongzhe Li, Yiling Lu, Joel Greshock, 2014, Cancer cell.

Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis

Chiara Benedetto, Herbert Yu, Yuanyuan Fu, 2015, PloS one.

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

George Coukos, Michael N Liebman, Marco Massobrio, 2003, The New England journal of medicine.